EPA REGULATORY UPDATE

Size: px
Start display at page:

Download "EPA REGULATORY UPDATE"

Transcription

1 SOCIETY OF QUALITY ASSURANCE REGULATORY FORUM EPA REGULATORY UPDATE Linthicum Heights, Maryland January 24, 2008 Robert Cypher United States Environmental Protection Agency 2/13/2008 SQA Baltimore 1

2 ANY UNITED STATES GLP FIELD TRIAL MAY BE SUBMITTED TO OTHER COUNTRIES IN THE WORLD 2/13/2008 SQA Baltimore 2

3 FY INSPECTIONS BY DISCIPLINE Field Sites 36.5% 35 7 Toxicology 7.3% Chemistry 12.5% Others 4.2% 22 4 Product Chemistry 22.9% Antimicrobial 4.2% Insecticide 12.5% Total Inspections 96 Total data audits 304 Human studies 11 2/13/2008 SQA Baltimore 3

4 FIELD SITES INSPECTED - FY2007 Total field sites inspected 35 IR-4 field sites 13 (37%) Non IR-4 field sites 22 (63%) 2/13/2008 SQA Baltimore 4

5 FY2007 FIELD SITES INSPECTIONS Total Inspections Field Sites Gov/Public/Academia No. Inspections In Compliance (Inspector's Findings) % Non-Gov/Private Sector No. Inspections In Compliance (Inspector's Findings) % /13/2008 SQA Baltimore 5

6 COMPLIANCE PROFILE FY 2007 High Level Violations FIELD SITES Total GLP Inspections 96 Inspections 35 In Compliance 34 (97%) 2/13/2008 SQA Baltimore 6

7 GLP COMPLIANCE RATE - FY2007 Inspections Compliance Rate (No findings) Compliance Rate (High Level Violations) % 30 80% % % 100% 25% 50% 83% 100% 58% 75% 50% 68% 100% 100% 0 Field Toxicology Antimicrobial Analy Chemistry Insecticide Eff Prod Chemistry Others 2/13/2008 SQA Baltimore 7

8 FIELD SITES FY2004-FY2007 COMPLIANCE STATISTICS 120 Fy2004 FY2005 FY2006 FY % 77% 74% 80% 94% 97% 89% 97% Total Inspections Field Sites In Compliance In Compliance (No findings) (High level violations) 2/13/2008 SQA Baltimore 8

9 Subpart A Subpart B Subpart C Subpart D Subpart E Subpart F Subpart G Subpart J Science Issues FY 2007 GLP VIOLATIONS FIELD SITES /13/2008 SQA Baltimore 9

10 GLP FIELD SITE VIOLATIONS BY CITATION FY2007 Subpart B Training records, experience and job descriptions not available Final report does not reflect raw data 2/13/2008 SQA Baltimore 10

11 GLP FIELD SITE VIOLATIONS BY CITATION FY2007 Subpart E SOP deviations Reagents were not labeled according to GLP Experimental dates were determined arbitrarily 2/13/2008 SQA Baltimore 11

12 GLP FIELD SITE VIOLATIONS BY CITATION FY2007 Subpart G Changes to protocol were not signed by the Study Director PI do not have a complete protocol Activity and observations were not recorded 2/13/2008 SQA Baltimore 12

13 GLP FIELD SITE VIOLATIONS BY CITATION FY2007 Subpart J Test facility (Study Director) did not have a copy of the final report Final report does not reflect raw data 2/13/2008 SQA Baltimore 13

14 FY2007 STUDY REJECTIONS Product chemistry Five (5) studies One (1) laboratory 2/13/2008 SQA Baltimore 14

15 EPA INTERNATIONAL ACTIVITIES OECD MUTUAL ACCEPTANCE OF DATA (MAD) Chair of OECD GLP Working Group EPA Full members of OECD MAD 27 Members of MAD (non OECD members) Provisional members of MAD (non OECD members) 3 (South Africa, Slovenia, Israel) 4 (India, Singapore, Brazil, Argentina) Guidance document Archives Establishment and Control of Archives that Operate in Compliance with Principles of Good Laboratory Practice 2/13/2008 SQA Baltimore 15

16 GUIDANCE DOCUMENTS RELEVANT TO FIELD RESEARCHERS No. 1 The OECD Principles of GLP No. 4 Quality Assurance and GLP No. 5 Compliance of Laboratory Suppliers with GLP Principles No. 6 The Application of the GLP Principles to Field Studies No. 8 The Role and Responsibility of the Study Director in GLP Studies No. 10 The Application of the Principles of GLP to Computerized Systems No. 11 The Role and Responsibilities of the Sponsor in the Application of the Principles of GLP No. 13 The Application of the Principles of GLP to the Organization and Management of Multisite Studies No. 15 Establishment and Control of Archives that Operate in Compliance with Principles of Good Laboratory Practice. 2/13/2008 SQA Baltimore 16

17 OECD MUTUAL ACCEPTANCE OF DATA WHAT IS NEW? 2/13/2008 SQA Baltimore 17

18 THE WORLD ACCORDING TO GLP THE WORLD ACCORDING TO GLP THE WORLD ACCORDING TO GLP THE WORLD ACCORDING TO GLP THE WORLD ACCORDING TO GLP THE WORLD ACCORDING TO GLP THE WORLD ACCORDING TO GLP THE WORLD ACCORDING TO GLP THE WORLD ACCORDING TO GLP THE WORLD ACCORDING TO GLP 2/13/2008 SQA Baltimore 18

19 Brazil India China Argentina Singapore Taiwan Turkey Malaysia 2/13/2008 SQA Baltimore 19

20 OECD ACTIVITIES No revisions of OECD Principles of GLP No changes of GLP affecting field research in the US Field studies conducted according to EPA GLP in the US will be accepted for review in other OECD Member countries China* Turkey* Malaysia* Taiwan* Brazil* Argentina Other countries * Have visited EPA 2/13/2008 SQA Baltimore 20

21 OECD FUTURE ACTIVITIES 1) OECD event with industry in April 2008 in Rome, NAICC participates 2) GLP inspectors training Israel, September ) Evaluation of GLP compliance monitoring programs of Members of MAD 4) Evaluation of US EPA GLP program in 2010, FDA in ) Evaluation of India s GLP program in February /13/2008 SQA Baltimore 21

22 Foreign countries inquiring about GLP compliance status of US Field Sites and laboratories If your facility has not been inspected for the discipline they are interested in, your study will not be accepted by foreign countries 2/13/2008 SQA Baltimore 22

23 FUTURE ACTIVITIES Biotechnology studies Nanotechnology Human testing 2/13/2008 SQA Baltimore 23

24 Robert Cypher U.S. Environmental Protection Agency 1200 Pennsylvania Ave., NW (2225A) Washington, DC Tel Fax /13/2008 SQA Baltimore 24

GLP in the European Union Ecolabel detergents, GLP and accreditation

GLP in the European Union Ecolabel detergents, GLP and accreditation GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European

More information

GLP Update and Hot Topics

GLP Update and Hot Topics GLP Update and Hot Topics RQA Annual Conference Mark Goodwin 9 Nov 2016 Introduction International GLP Updates OECD including MAD Agreement EC/ EMA US FDA & US EPA UK GLP Update MHRA MHRA GLP Deficiencies

More information

Singapore s Progress on GLP and MAD

Singapore s Progress on GLP and MAD 2010/SOM1/CD/WKSP/025 Agenda Item: Afternoon Session I Singapore s Progress on GLP and MAD Submitted by: Singapore Case Study Workshop on the Chemicals Sector - From Principles to Practice Hiroshima, Japan

More information

TERMS AND CONDITIONS NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY

TERMS AND CONDITIONS NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY TERMS AND CONDITIONS OF NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY FOR OBTAINING AND MAINTAINING ITS GLP CERTIFICATION BY A TEST FACILITY Document No.GLP-101 Version/Issue

More information

Comparability and quality of experimental data under different quality systems. S. Caroli Istituto Superiore di Sanità Rome

Comparability and quality of experimental data under different quality systems. S. Caroli Istituto Superiore di Sanità Rome Comparability and quality of experimental data under different quality systems S. Caroli Istituto Superiore di Sanità Rome Programme of this presentation Part I. Background information Part II. Key aspects

More information

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014 Good Laboratory Practice EU-Serbia screening meeting Brussels, 19 June 2014 Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role

More information

FoodDrinkEurope Position on GLP studies

FoodDrinkEurope Position on GLP studies FoodDrinkEurope Position on GLP studies Content of the presentation Introduction to GLP Importance of GLP for the food industry Use of GLP based on the example of novel foods Conclusions GLP what is it?

More information

Guidance on the GLP Requirements for Peer Review of Histopathology Advisory Document

Guidance on the GLP Requirements for Peer Review of Histopathology Advisory Document GLP Roundtable 2014 Guidance on the GLP Requirements for Peer Review of Histopathology Advisory Document Dr. Elisabeth Klenke, Head Preclinical Review and GLP Monitoring Compliance Unit Swissmedic Swiss

More information

Specific Accreditation Guidance OECD GLP

Specific Accreditation Guidance OECD GLP Specific Accreditation Guidance OECD GLP Information for GLP Study Sponsors January 2018 Copyright National Association of Testing Authorities, Australia 2013 This publication is protected by copyright

More information

Standard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes

Standard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes Scope To describe the procedure for EFSA to request on a yearly or ad-hoc basis the performance of GLP studies audits by the GLP Monitoring Authorities. To lay down criteria for the selection of the GLP

More information

GROCERY MANUFACTURERS ASSOCIATION. Science Forum. Connecting Sound Science and Responsible Solutions

GROCERY MANUFACTURERS ASSOCIATION. Science Forum. Connecting Sound Science and Responsible Solutions GROCERY MANUFACTURERS ASSOCIATION Science Forum Connecting Sound Science and Responsible Solutions FSMA Implementation Michael M. Landa Director, Center for Food Safety and Applied Nutrition Food and Drug

More information

WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract Research Organization

WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract Research Organization SOP 408.4 Annex C 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int Part 1: General information WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract

More information

GLP VIRUCIDAL TESTING OF ZEROMOLD PLUS FOR HIV-1

GLP VIRUCIDAL TESTING OF ZEROMOLD PLUS FOR HIV-1 Southwest Research Institute Page 1 of 8 Microencapsulation and Nanomaterials Department Amended Final Report: GLP Virucidal Testing of ZeroMold Plus for HIV-1 Protocol No.: GLP-SP-239 FINAL REPORT STUDY

More information

About NATA and GLP recognition. Information on the OECD Principles of Good Laboratory Practice compliance monitoring program

About NATA and GLP recognition. Information on the OECD Principles of Good Laboratory Practice compliance monitoring program Information on the OECD Principles of Good Laboratory Practice compliance monitoring program September 2018 Copyright National Association of Testing Authorities, Australia 2013 This publication is protected

More information

Global EHS Resource Center

Global EHS Resource Center Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research

More information

Clinical Trials in Third Countries

Clinical Trials in Third Countries Clinical Trials in Third Countries meeting, 29 January 2015 Presented by Fergus Sweeney European Medicines Agency An agency of the European Union Overview Distribution of clinical trials submitted in support

More information

Test Article Analyses in Compliance with Good Laboratory Practice in Japan: Circumstances and Changes

Test Article Analyses in Compliance with Good Laboratory Practice in Japan: Circumstances and Changes Test Article Analyses in Compliance with Good Laboratory Practice in Japan: Circumstances and Changes Harumi Namiki 1, *, Tetsuya Shigeta 2, Yoshitaka Ino 3, Kanzo Kimura 4, Katsutoshi Inaba 5, Sachio

More information

July 11, Dear Mr. Derfler:

July 11, Dear Mr. Derfler: July 11, 2005 Mr. Philip Derfler Assistant Administrator Office of Policy, Program and Employee Development Food Safety and Inspection Service Room 350 Administration Building U.S. Department of Agriculture

More information

The regulatory landscape Stephen White on behalf of the EBF

The regulatory landscape Stephen White on behalf of the EBF The regulatory landscape Stephen White on behalf of the EBF http://www.europeanbioanalysisforum.eu Overview 1. MIST and DDI Guideline 2. Regulatory landscape for BA 3. Tiered Approach on BA of metabolites

More information

GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP INSPECTIONS BY COMPETENT AUTHORITIES OF THE DIFFERENT MEMBER STATES

GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP INSPECTIONS BY COMPETENT AUTHORITIES OF THE DIFFERENT MEMBER STATES EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 5 November 2008 ENTR/F/2/SF D(2008) 34957 GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON

More information

Update from FDA Office of Regulatory Affairs

Update from FDA Office of Regulatory Affairs Update from FDA Office of Regulatory Affairs Ellen F. Morrison Assistant Commissioner for Medical Products and Tobacco Operations Office of Regulatory Affairs U.S. Food and Drug Administration 1 The Impact

More information

Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH)

Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH) Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH) Presentation to ICDRA Members 16 September 2008 YEE Shen Kuan Division Director

More information

CURRICULUM VITAE. Ezzeddine Boutrif

CURRICULUM VITAE. Ezzeddine Boutrif CURRICULUM VITAE Ezzeddine Boutrif PERSONAL Date of Birth: 20 December 1948 Place of Birth: Citizenship: Korba, Tunisia Tunisian Telephone No.: +39 338 126 3209 Fax No.: Email address: ezzeddine.boutrif@gmail.com

More information

Quality Assurance Standard. Implemented 1991 Revised Version 3.0

Quality Assurance Standard. Implemented 1991 Revised Version 3.0 Implemented 1991 Revised 2006 Version 3.0 IQPP Contents I. Introduction... 3 II. Definitions... 4 III. PPTA Source Quality Assurance Principles... 4 IV. Audits and Compliance Verification... 5 Page 2 IQPP

More information

LIVE INTERACTIVE YOUR DESKTOP. Food Recall Process. Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement

LIVE INTERACTIVE YOUR DESKTOP. Food Recall Process. Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement LIVE INTERACTIVE LEARNING @ YOUR DESKTOP Food Recall Process Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement Wednesday, December 9, 2009 LEGAL ISSUES Code of Federal Regulations

More information

EFSA Statement regarding the EU assessment of glyphosate and the socalled

EFSA Statement regarding the EU assessment of glyphosate and the socalled EFSA Statement regarding the EU assessment of glyphosate and the socalled Monsanto papers Background On 29 May 2017, EFSA received a request from the European Commission to produce a statement concerning

More information

Final Report. Acute oral toxicity study in Wistar rats. Mr. S. Haribabu, B Tech (Biotech), MSc

Final Report. Acute oral toxicity study in Wistar rats. Mr. S. Haribabu, B Tech (Biotech), MSc Study Title Test Item Study Director Sponsor Study Monitor Test Facility Acute oral toxicity study in Wistar rats Nualgi Nano Nutrients Mr. S. Haribabu, B Tech (Biotech), MSc Nualgi Nano Biotech Co 651,

More information

Overview of Dietary Supplement GMP Inspection Trends Quality Session 6

Overview of Dietary Supplement GMP Inspection Trends Quality Session 6 Overview of Dietary Supplement GMP Inspection Trends Quality Session 6 Presented by: Dean R. Cirotta, MBA President & Chief Operating Officer EAS Consulting Group, LLC 1700 Diagonal Road, Suite 750 Alexandria,

More information

Standard Operating Procedures (SOP) Research and Development Office

Standard Operating Procedures (SOP) Research and Development Office Standard Operating Procedures (SOP) Research and Development Office Title of SOP: GCP Inspection Procedures (MHRA) SOP Number: 15 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review

More information

Should There be a Single Food Safety Agency? (The Consumer Perspective) David W. Plunkett

Should There be a Single Food Safety Agency? (The Consumer Perspective) David W. Plunkett Should There be a Single Food Safety Agency? (The Consumer Perspective) David W. Plunkett Senior Staff Attorney June 10, 2008 Consumer Interest in Reform Consequences of foodborne illness Sickens 76 million,

More information

Globalization, Challenges, and Global Solutions

Globalization, Challenges, and Global Solutions Globalization, Challenges, and Global Solutions Deborah M. Autor, Esq. Director, Office of Compliance Center for Drug Evaluation and Research IOM Meeting on Strengthening Core Elements of Regulatory Systems

More information

PRODUCT STUDY TITLE DATA REQUIREMENT AUTHOR STUDY COMPLETED ON PERFORMING LABORATORY LABORATORY STUDY NUMBER

PRODUCT STUDY TITLE DATA REQUIREMENT AUTHOR STUDY COMPLETED ON PERFORMING LABORATORY LABORATORY STUDY NUMBER Product Safety Laboratories 2394 Highway 130 Dayton, NJ 08810 Tel: 732.438.5100 Fax: 732.355.3275 e-mail: PSL@productsafetylabs.com PRODUCT Stalosan F STUDY TITLE Acute Dermal Toxicity Study in Rats -

More information

Proposed FDA Food Safety Modernization Act:

Proposed FDA Food Safety Modernization Act: Proposed FDA Food Safety Modernization Act: Its impact on distillers production and sales Paula Emberland Business Analyst History of the FDA 1862 Beginning of Bureau of Chemistry 1927 Bureau of Chemistry

More information

Public Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas

Public Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas 75204-3128 March 30, 2010 2010-DAL-WL-08 CERTIFIED

More information

Best Practices in FDA 483 and Warning Letter Management and Recovery

Best Practices in FDA 483 and Warning Letter Management and Recovery Best Practices in FDA 483 and Warning Letter Management and Recovery Elaine C. Messa, RAC Director, Medical Device Quality Systems and Compliance Practice This document is intended to facilitate an oral

More information

Page 1132

Page 1132 Page 1131 Page 1132 Page 1133 Page 1134 Page 1135 Huntingdon Life Sciences 03-6140 Page 6. Final Report TABLE OF CONTENTS Page 1136 COVER PAGE...1 GLP STATEMENT...2 SIGNATURE PAGE...3 QUALITY ASSURANCE

More information

MHRA Pharmacovigilance System Master File (PSMF) Inspection Findings

MHRA Pharmacovigilance System Master File (PSMF) Inspection Findings MHRA Pharmacovigilance System Master File (PSMF) Inspection Findings Gretel Sakyi Medical Information and Patient Safety Manager AstraZeneca UK 07 June 2018 Agenda MHRA inspections How inspectors use the

More information

34th SQA Annual Meeting

34th SQA Annual Meeting 34th SQA Annual Meeting Registration Brochure www.sqa.org/sqa2018-1 - The Wonderful World of Quality The Society of Quality Assurance invites you to Anaheim, California for the 34th SQA Annual Meeting

More information

Role of NRA in Promoting GMP-compliant Blood Management Practices - The Chinese Taipei Experience-

Role of NRA in Promoting GMP-compliant Blood Management Practices - The Chinese Taipei Experience- 3rd APEC Blood Supply Chain Policy Forum Role of NRA in Promoting GMP-compliant Blood Management Practices - The Chinese Taipei Experience- Ying-Hua (Ellen), Chen Section Chief / GMP Inspector GMP Inspectorate

More information

GLOBAL BIOANALYSIS CONSORTIUM

GLOBAL BIOANALYSIS CONSORTIUM GLOBAL BIOANALYSIS CONSORTIUM Scope and Regulations Harmonization Team: A1 (Work in Progress) John Smeraglia on behalf of the HT-A1 A1: Scope and regulations Team members: Team lead Region Expertise Surendra

More information

Regulatory Update: Food Safety and Nutrition

Regulatory Update: Food Safety and Nutrition Regulatory Update: Food Safety and Nutrition Ricardo Carvajal Hyman, Phelps & McNamara, P.C. www.hpm.com www.fdalawblog.net North American Millers Association March 2015 Today s Agenda FSMA Update Biological

More information

METHODOLOGIES FOR INTERMITTENT AND SHORT-TERM EXPOSURE TO CARCINOGENS SUBCOMMITTEE

METHODOLOGIES FOR INTERMITTENT AND SHORT-TERM EXPOSURE TO CARCINOGENS SUBCOMMITTEE METHODOLOGIES FOR INTERMITTENT AND SHORT-TERM EXPOSURE TO CARCINOGENS SUBCOMMITTEE Mission The mission of the MISTEC Subcommittee is to develop methodologies for establishing appropriate dose-metrics to

More information

NIH StrokeNet Network Standard Operating Procedure

NIH StrokeNet Network Standard Operating Procedure 1. PURPOSE The purpose of this SOP is to outline procedures for Institutional Review Board (IRB) approval and oversight of National Institutes of Health (NIH) StrokeNet affiliated protocols conducted by

More information

SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH

SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH IN RATS SUB CHRONIC ORAL TOXICITY WITH NHH 44 Bt-COTTON SEEDS Report for: UNIVERSITY OF AGRICULTURAL SCIENCES AGRICULTURAL RESEARCH STATION DHARWAD-580007 KARNATAKA Guidelines: DBT, Guidelines for Toxicity

More information

Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration

Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration Evolving FDA s Approach to Pharmaceutical Quality Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IPAC-RS/University of Florida Orlando Inhalation

More information

Committed to Environment, Health, & Safety

Committed to Environment, Health, & Safety Committed to Environment, Health, & Safety Environment, Health, and Safety Management System and Policy of W. R. Grace & Co. November 8, 2018 The Grace Environment, Health, and Safety Management System,

More information

Planning For The FDA s 'Deeming Rule' For E- Cigarettes

Planning For The FDA s 'Deeming Rule' For E- Cigarettes Law360, New York (September 21, 2015, 3:39 PM ET) -- The 2009 Family Smoking Prevention and Tobacco Control Act (TCA)[1] gave the U.S. Food and Drug Administration the authority to oversee the manufacture,

More information

HALAL FOOD AND SAFETY COMPLIANCE AGROASIA 2011 HALAL INDUSTRY RESEARCH CENTRE

HALAL FOOD AND SAFETY COMPLIANCE AGROASIA 2011 HALAL INDUSTRY RESEARCH CENTRE HALAL FOOD AND SAFETY COMPLIANCE AGROASIA 2011 July 2010 Page 1 Revolutionizing Assistance in the disposal Industry of in Prime a Shariah Liquid Compliant Emulsion way Industries! Halal Industry Research

More information

Final Report. Acute dermal toxicity study in Wistar rats. Mr. M. Vasanthan, M Tech (Biotech)

Final Report. Acute dermal toxicity study in Wistar rats. Mr. M. Vasanthan, M Tech (Biotech) Study Title Test Item Study Director Sponsor Study Monitor Test Facility Acute dermal toxicity study in Wistar rats Nualgi Nano Nutrients Mr. M. Vasanthan, M Tech (Biotech) Nualgi Nano Biotech Co 651,

More information

AFDO Conference June 9, Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide

AFDO Conference June 9, Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide AFDO Conference June 9, 2009 Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide Government Agencies 483 observations A violation of the FD&C Act involving

More information

Implementing of Good Laboratory Practice (GLP) in Food Analysis Laboratories of Baghdad University

Implementing of Good Laboratory Practice (GLP) in Food Analysis Laboratories of Baghdad University ISSN (Online): 2319-764 Index Copernicus Value (215): 78.96 Impact Factor (215): 6.391 Implementing of Good Laboratory Practice (GLP) in Food Analysis Laboratories of Baghdad University Mahmud Abdullah

More information

- Network for Excellence in Health Innovation

- Network for Excellence in Health Innovation Real-world evidence is evidence from any and all sources of data that may contribute to more effective health care, including health care best tailored to the needs of individual patients. - Network for

More information

For personal use only

For personal use only Sirtex Medical Limited (ASX:SRX) Macquarie Inaugural Annual Emerging Healthcare Conference Mr Gilman Wong, CEO Mr Darren Smith, CFO Dr David Cade, CMO Wednesday, 10 October 2012 Macquarie Securities Group

More information

Overview of FDA Oversight and Enforcement on Drug Compounding

Overview of FDA Oversight and Enforcement on Drug Compounding Overview of FDA Oversight and Enforcement on Drug Compounding Ruey Ju, Pharm.D., J.D. Senior Advisor for Compounding Compliance and Enforcement (Acting) Center for Drug Evaluation and Research Today s

More information

Division of Research University Policy

Division of Research University Policy Division of Research University Policy SUBJECT: Effective Date: Policy Number: SATELLITE ANIMAL HOUSING FACILITIES June 24, 2016 Supersedes: August 22, 2014 1 5 Responsible Authorities: Vice President,

More information

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

Recommended composition of influenza virus vaccines for use in the 2007 influenza season Recommended composition of influenza virus vaccines for use in the 2007 influenza season September 2006 This recommendation relates to the composition of vaccines for the forthcoming winter in the southern

More information

2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation

2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation 2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation Submitted by: United States Life Sciences Innovation Forum Sendai,

More information

FSMA: Implementation and Impact on Global food Industry and role of FSPCA in Preventive Controls Education and Outreach

FSMA: Implementation and Impact on Global food Industry and role of FSPCA in Preventive Controls Education and Outreach FSMA: Implementation and Impact on Global food Industry and role of FSPCA in Preventive Controls Education and Outreach 56th Annual Tanner Lecture Chicago section IFT Purnendu C. Vasavada Professor Emeritus,

More information

Agency Information Collection Activities; Submission for Office of Management and

Agency Information Collection Activities; Submission for Office of Management and This document is scheduled to be published in the Federal Register on 03/04/2019 and available online at https://federalregister.gov/d/2019-03824, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Informed Consent Procedures and Writing Informed Consent Forms

Informed Consent Procedures and Writing Informed Consent Forms STANDARD OPERATING PROCEDURE Informed Consent Procedures and Writing Informed Consent Forms Standard Operating Procedure Western Health SOP reference 006 Version: 2.0 dated December 2015 Effective Date

More information

A GLOBAL LEADER IN PERSONALIZED NUTRITION

A GLOBAL LEADER IN PERSONALIZED NUTRITION A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking

More information

AN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z

AN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z AN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z AMENDED FINAL REPORT Author Deborah A Douds, M.S. Original Study Completion Date July 8, 1997 Amended Study Completion Date November 19, 1997 Performing

More information

National Safety Programme Implementation

National Safety Programme Implementation SUDAN CIVIL AVIATION AUTHORITY National Safety Programme Implementation SUDAN S EXPERIENCE Presentation to the Third Meeting of the Director s General of the Middle East Region Doha Qatar, 27 to 29 April

More information

Japanese regulations and JSQA update. Tadahiro Yoshiyama International Affairs Committee Director of GLP Division November 11, 2016

Japanese regulations and JSQA update. Tadahiro Yoshiyama International Affairs Committee Director of GLP Division November 11, 2016 Japanese regulations and JSQA update Tadahiro Yoshiyama International Affairs Committee Director of GLP Division November 11, 2016 Contents Japanese regulatory updates of the GxP systems Recent activities

More information

Shawn Stevens Food Industry Consultant and Lawyer

Shawn Stevens Food Industry Consultant and Lawyer Shawn Stevens Food Industry Consultant and Lawyer stevens@foodindustrycounsel.com 920.698.2561 COMPLYING WITH FSMA S PREVENTIVE CONTROL RULE AS A SMALL BUSINESS COMPLYING WITH FSMA S PREVENTIVE CONTROL

More information

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Outline Herbal Medicines in the U.S. Herbal Medicines in EU Herbal Medicines in Australia Herbal Medicines in Asia & Taiwan Regulatory Strategy

More information

Inter-Agency Overlap and Jurisdictional Boundaries

Inter-Agency Overlap and Jurisdictional Boundaries Inter-Agency Overlap and Jurisdictional Boundaries FDLI Food Advertising, Labeling, and Litigation Conference September 14, 2017 Jessica P. O Connell Covington & Burling LLP jpoconnell@cov.com 1 FDA Approach/Perspective

More information

Cutanea Life Sciences, Inc. Comprehensive Compliance Program

Cutanea Life Sciences, Inc. Comprehensive Compliance Program Cutanea Life Sciences, Inc. Comprehensive Compliance Program Cutanea engages in research, development, manufacture and marketing of dermatology products, including commercialization of those products.

More information

Overview of Regulatory Science of Food Contact Substances

Overview of Regulatory Science of Food Contact Substances Overview of Regulatory Science of Food Contact Substances Michael A. Adams, PhD Deputy Director, Office of Food Additive Safety FDA, Center for Food Safety and Applied Nutrition 5001 Campus Drive, College

More information

Residue Chemistry Studies for Veterinary Drugs. Human Food Safety Assessment. Presentation Topic. Improving residue chemistry submissions

Residue Chemistry Studies for Veterinary Drugs. Human Food Safety Assessment. Presentation Topic. Improving residue chemistry submissions Residue Chemistry Studies for Veterinary Drugs Julia A. Oriani, Ph.D. Food and Drug Administration Center for Veterinary Medicine Division of Human Food Safety Human Food Safety Assessment Risk = Hazard

More information

Using new scientific knowledge to update regulations in the U.S.

Using new scientific knowledge to update regulations in the U.S. Using new scientific knowledge to update regulations in the U.S. Maricel Maffini, Ph.D. Food Packaging Forum 5 October, 2017 US Food Additives Regulatory Program Administered by the Food and Drug Administration

More information

Calendar of Events. 1 2 June 2006 RAPS 2006 European Conference: EU Regulatory Response to Innovation and Global Competitiveness

Calendar of Events. 1 2 June 2006 RAPS 2006 European Conference: EU Regulatory Response to Innovation and Global Competitiveness Calendar of Events 31 May 2 June 2006 The Validation Manager Venue: Vienna, Austria. 1 2 June 2006 RAPS 2006 European Conference: EU Regulatory Response to Innovation and Global Competitiveness Venue:

More information

Global Regulation of Food Additives

Global Regulation of Food Additives Chapter 1 Global Regulation of Food Additives Downloaded via 148.251.232.83 on January 28, 2019 at 18:43:58 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published

More information

Assessing Drug Safety

Assessing Drug Safety Assessing Drug Safety Paul J. Seligman, MD, MPH Director Office of Pharmacoepidemiology & Statistical Science Center for Drug Evaluation & Research July 20, 2005 Institute of Medicine Committee 1 Agenda

More information

Heat and Freeze Sensitivity of Vaccines

Heat and Freeze Sensitivity of Vaccines Heat and Freeze Sensitivity of Vaccines DCVMN Workshop "Vaccine quality management systems for manufacturing excellence" Michael Rush, MBA Executive Director - Global Health Policy October 24-25, 2013

More information

Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory

Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory SQA National Meeting 29Mar2017 Carolyn Eberhardt, Principal Consultant, QC2 Mark Stiles, Senior Consultant, QC2 Comparison of Quality

More information

4/10/2017. Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory

4/10/2017. Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory SQA National Meeting 29Mar2017 Carolyn Eberhardt, Principal Consultant, QC2 Mark Stiles, Senior Consultant, QC2 Comparison of Quality

More information

Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801

Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801 Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801 Jarilyn Dupont, JD Director of Regulatory Policy, Office of Policy Office of Commissioner, U.S. Food

More information

GDUFA II User Fees. Update on Implementation

GDUFA II User Fees. Update on Implementation GDUFA II User Fees Update on Implementation Donal Parks, Director Division of User Fee Management and Budget Formulation OM CDER US FDA November 8, 2017 Outline Refresher on GDUFA II fee structure What

More information

February 2016 Melanie Harris Iowa RRT and Foodborne Illness Response Coordinator Iowa Department of Inspections and Appeals

February 2016 Melanie Harris Iowa RRT and Foodborne Illness Response Coordinator Iowa Department of Inspections and Appeals February 2016 Melanie Harris Iowa RRT and Foodborne Illness Response Coordinator Iowa Department of Inspections and Appeals Food and Lodging Regulation in General Department of Inspections and Appeals

More information

Current Developments in Guidance for Regulatory Bioanalysis

Current Developments in Guidance for Regulatory Bioanalysis Current Developments in Guidance for Regulatory Bioanalysis Dr Gerry McGuire Resolution Analytical Consultancy Ltd Edinburgh, Scotland UK gerry@resolutioneurope.com 1st MENA Regulatory Conference on Bioequivalence,

More information

Momentous gathering of the dental industry DenTech China 2017 The 21 st China International Exhibition & Symposium on Dental Equipment, Technology &

Momentous gathering of the dental industry DenTech China 2017 The 21 st China International Exhibition & Symposium on Dental Equipment, Technology & Momentous gathering of the dental industry DenTech China 2017 The 21 st China International Exhibition & Symposium on Dental Equipment, Technology & Products, successfully held in Shanghai, China from

More information

STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE

STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE VICH GL54 (SAFETY) ARfD November 2016 For Implementation at Step 7 STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE (ARfD)

More information

FSMA, FSVP, and FCS. Deborah Attwood May 12, 2016 Global Food Contact 2016

FSMA, FSVP, and FCS. Deborah Attwood May 12, 2016 Global Food Contact 2016 FSMA, FSVP, and FCS Deborah Attwood May 12, 2016 Global Food Contact 2016 Food Safety Modernization Act (FSMA) Became law in January 2011 Improves safety and security of food supply through prevention,

More information

What Do IACP Members Think?

What Do IACP Members Think? What Do IACP Members Think? Results of a National Survey of Compounding Practitioners February 27, 2013 Final Summary Results What Do Compounders Think? National Survey of 2,857 pharmacists and technicians

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int Part 1: General information Name of Manufacturer Prequalification Team WHO PUBLIC INSPECTION

More information

Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations

Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,

More information

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective? FOURIER STUDY Did the study achieve its main objective? 2 15% 1 5% 9.8% YES FOURIER compared Repatha with placebo in patients who were taking a statin and had hardening or narrowing of the arteries and

More information

Family Smoking Prevention and Tobacco Control Act. Comments regarding crop protection agents

Family Smoking Prevention and Tobacco Control Act. Comments regarding crop protection agents Family Smoking Prevention and Tobacco Control Act (PUBLIC LAW 111-31 JUNE 22, 2009) Comments regarding crop protection agents Presentation Objectives What is the intent of FDA in regulating CPAs? What

More information

Monitoring EU Agri-Food Trade: Development until February 2018

Monitoring EU Agri-Food Trade: Development until February 2018 Monitoring EU Agri-Food Trade: Development until February 2018 February 2018: a further increase in EU agri-food trade surplus The monthly value of EU agri-food exports in February 2018 decreased slightly

More information

Formation of the Institutional Base and Providing Creation of the System of Good Laboratory Practice in accordance with OECD Requirements

Formation of the Institutional Base and Providing Creation of the System of Good Laboratory Practice in accordance with OECD Requirements Centre for Economic and Financial Research at New Economic School #38 December 2013 Formation of the Institutional Base and Providing Creation of the System of Good Laboratory Practice in accordance with

More information

Development of ESM Framework

Development of ESM Framework Ministry of the Environment Government of Japan Development of ESM Framework - ESM Discussion under the Basel Convention - Shunichi Honda PhD Section Chief, Office of Waste Disposal Management Ministry

More information

SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH. ACUTE ORAL TOXICITY STUDY IN RATS WITH Cry 1 C a 1 PROTEIN

SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH. ACUTE ORAL TOXICITY STUDY IN RATS WITH Cry 1 C a 1 PROTEIN ACUTE ORAL TOXICITY STUDY IN RATS WITH Cry 1 C a 1 PROTEIN REPORT FOR METAHELIX LIFE SCIENCES PVT. LTD., PLOT NO.-3, KIADB 4 TH PHASE, BOMMASANDRA, BANGALORE-500 099, INDIA. GUIDELINES DBT Guidelines TEST

More information

Malaysia s Experience in Regulating the Medical Device Sector

Malaysia s Experience in Regulating the Medical Device Sector 2011/SOM1/SCSC/CON1/012 Session 7 Malaysia s Experience in Regulating the Medical Device Sector Submitted by: Malaysia 6 th Conference on Good Regulatory Practice Washington, D.C., United States 1-2 March

More information

SOP-QA-30 V Scope

SOP-QA-30 V Scope Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Joanne Rodger, Senior R&D Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys,

More information

Report. Uganda Pharmaceutical Sector Scan JUNE 2010

Report. Uganda Pharmaceutical Sector Scan JUNE 2010 Report On the Uganda Pharmaceutical Sector Scan Part of Component 1 of MeTA Baseline Assessments JUNE 2010 Drafted by consultants: 1. Samuel Balyejjusa, B.Pharm., MPH 2. Paschal Mujasi, B.Pharm., MBA 3.

More information

cgmp (21 CFR 111) Regulation and Compliance Overview

cgmp (21 CFR 111) Regulation and Compliance Overview cgmp (21 CFR 111) Regulation and Compliance Overview Neogen Effective Compliance Seminar September 23, 2014 Michael McGuffin President, American Herbal Products Association mmcguffin@ahpa.org Regulation

More information

Sandoz Inc. 12-Aug-08

Sandoz Inc. 12-Aug-08 Sandoz Inc. 12-Aug-08 Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District Office 60 8th Street, N.E. Atlanta, Georgia 30309 August 12, 2008 VIA FEDERAL

More information

Sirtex Medical Limited (ASX:SRX)

Sirtex Medical Limited (ASX:SRX) Sirtex Medical Limited (ASX:SRX) Macquarie Australia Conference Mr Gilman Wong, CEO Dr David Cade, CMO Sydney, 8 th May 2014 SIR-Spheres is a registered trademark of Sirtex SIR-Spheres Pty Ltd 1 Understanding

More information

Appendix N Pilot Program Question and Answer Version 5.0 6/23/2017

Appendix N Pilot Program Question and Answer Version 5.0 6/23/2017 Appendix N Pilot Program Question and Answer Version 5.0 6/23/2017 This Q&A document answers questions that have been submitted to the NCIMS Appendix N Modification Study Committee. The start date for

More information